Evidence map›Paper›PMID 30781838›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Synthesis and Characterization of Elongated-Shaped Silver Nanoparticles as a Biocompatible Anisotropic SERS Probe for Intracellular Imaging: Theoretical Modeling and Experimental Verification.

Carlos Caro, Pedro Quaresma, Eulália Pereira, Jaime Franco, Manuel Pernia Leal, Maria Luisa García-Martín, Jose Luis Royo, Jose Maria Oliva-Montero, Patrick Jacques Merkling, Ana Paula Zaderenko and 2 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carlos CaroDepartment of Physical, Chemical and Natural Systems, Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013 Seville, Spain. ccaro@bionand.es.ORCID 0000-0003-4758-3816
Pedro QuaresmaDepartamento de Química e Bioquímica, LAQV-REQUIMTE, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal. pedro.cq1@gmail.com.ORCID 0000-0001-7032-7760
Eulália PereiraDepartamento de Química e Bioquímica, LAQV-REQUIMTE, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal. efpereir@fc.up.pt.
Jaime FrancoCABIMER, Andalusian Center for Molecular Biology and Regenerative Medicine, Av. Americo Vespucio, 24, 41092 Sevilla, Spain. jaime.munoz@cabimer.es.
Manuel Pernia LealBIONAND, Andalusian Centre for Nanomedicine and Biotechnology, Junta de Andalucía, Universidad de Málaga, 29590 Málaga, Spain. mpernia@us.es.ORCID 0000-0001-8160-0574
Maria Luisa García-MartínBIONAND, Andalusian Centre for Nanomedicine and Biotechnology, Junta de Andalucía, Universidad de Málaga, 29590 Málaga, Spain. mlgarcia@bionand.es.ORCID 0000-0002-2257-7682
Jose Luis RoyoDepartment of Biochemistry, Molecular Biology and Immunology, Universidad de Málaga, 29071 Málaga, Spain. joseluisroyo@uma.es.
Jose Maria Oliva-MonteroDepartment of Physical, Chemical and Natural Systems, Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013 Seville, Spain. josolimon@gmail.com.ORCID 0000-0002-8314-5883
Patrick Jacques MerklingDepartment of Physical, Chemical and Natural Systems, Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013 Seville, Spain. pjmerx@upo.es.ORCID 0000-0003-4359-4278
Ana Paula ZaderenkoDepartment of Physical, Chemical and Natural Systems, Universidad Pablo de Olavide, Carretera de Utrera Km 1, 41013 Seville, Spain. apzadpar@upo.es.
David PozoCABIMER, Andalusian Center for Molecular Biology and Regenerative Medicine, Av. Americo Vespucio, 24, 41092 Sevilla, Spain. david.pozo@cabimer.es.ORCID 0000-0002-3732-4960
Ricardo FrancoDepartamento de Química, UCIBIO, REQUIMTE, Faculdade de Ciências, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal. rft@fct.unl.pt.ORCID 0000-0002-5139-2871

Funding

ROLE OF VITRONECTIN IN TUMOR CELL METASTASISK08CA001600 · NCI · UNIVERSITY OF WASHINGTON · PI CHERNY, RICHARD C · 1991 to 1992
–
Fundação para a Ciência e a Tecnologia UID/QUI/50006/2013-POCI/01/0145/FEDER/007265Ministerio de Ciencia e Innovación PI14-1600
6 · The paper itself

Abstract

Progress in the field of biocompatible SERS nanoparticles has promising prospects for biomedical applications. In this work, we have developed a biocompatible Raman probe by combining anisotropic silver nanoparticles with the dye rhodamine 6G followed by subsequent coating with bovine serum albumin. This nanosystem presents strong SERS capabilities in the near infrared (NIR) with a very high (2.7 × 10⁷) analytical enhancement factor. Theoretical calculations reveal the effects of the electromagnetic and chemical mechanisms in the observed SERS effect for this nanosystem. Finite element method (FEM) calculations showed a considerable near field enhancement in NIR. Using density functional quantum chemical calculations, the chemical enhancement mechanism of rhodamine 6G by interaction with the nanoparticles was probed, allowing us to calculate spectra that closely reproduce the experimental results. The nanosystem was tested in cell culture experiments, showing cell internalization and also proving to be completely biocompatible, as no cell death was observed. Using a NIR laser, SERS signals could be detected even from inside cells, proving the applicability of this nanosystem as a biocompatible SERS probe.

Indexed as

cancercell labelingdensity functional theory calculationsfinite element methodSERSsurface enhanced Raman scattering

Identifiers

PMID30781838
PMCPMC6409692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.